Redwoods Acquisition Corp. Files 8-K
Ticker: GRMLW · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1907223
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Redwoods Acquisition Corp. filed an 8-K on June 20, 2024, updating its corporate and financial status.
AI Summary
Redwoods Acquisition Corp. filed an 8-K on June 20, 2024, reporting on other events and financial statements. The company, incorporated in Delaware, is involved in the Biological Products sector. Its principal executive offices are located at 1115 Broadway, 12th Floor, New York, NY 10010.
Why It Matters
This filing provides an update on Redwoods Acquisition Corp.'s corporate activities and financial reporting, which is important for investors tracking the company's status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing with no immediate material events disclosed.
Key Numbers
- 001-41340 — SEC File Number (Identifies the company's filing with the SEC.)
- 86-2727441 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Redwoods Acquisition Corp. (company) — Registrant
- June 20, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 1115 Broadway, 12th Floor, New York, NY 10010 (address) — Principal executive offices
FAQ
What is the primary business of Redwoods Acquisition Corp.?
Redwoods Acquisition Corp. is in the Biological Products sector, specifically Biological Products (No Diagnostic Substances) [2836].
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 20, 2024.
Where are Redwoods Acquisition Corp.'s principal executive offices located?
The principal executive offices are located at 1115 Broadway, 12th Floor, New York, NY 10010.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the SEC file number for Redwoods Acquisition Corp.?
The SEC file number is 001-41340.
Filing Stats: 1,723 words · 7 min read · ~6 pages · Grade level 14.3 · Accepted 2024-06-20 13:14:35
Filing Documents
- ea0208158-8k425_redwoods.htm (8-K) — 42KB
- ea020815801ex99-1_redwoods.htm (EX-99.1) — 288KB
- ea020815801ex99-2_redwoods.htm (EX-99.2) — 320KB
- ex99-1_001.jpg (GRAPHIC) — 18KB
- ex99-1_002.jpg (GRAPHIC) — 12KB
- 0001213900-24-054153.txt ( ) — 990KB
- rwod-20240620.xsd (EX-101.SCH) — 4KB
- rwod-20240620_def.xml (EX-101.DEF) — 27KB
- rwod-20240620_lab.xml (EX-101.LAB) — 37KB
- rwod-20240620_pre.xml (EX-101.PRE) — 25KB
- ea0208158-8k425_redwoods_htm.xml (XML) — 7KB
01. Other Events
Item 8.01. Other Events As previously announced, Redwoods Acquisition Corp. (the "Company") entered into that certain business combination agreement, dated May 30, 2023, by and among the Company, ANEW MEDICAL, INC. ("ANEW"), a Wyoming corporation, and ANEW MEDICAL SUB, INC. ("Merger Sub"), a Wyoming corporation, pursuant to which Merger Sub will merge with and into ANEW with ANEW surviving as a wholly-owned subsidiary of the Company (the "Business Combination"). In connection with the Business Combination, the Company filed a registration statement on Form S-4 (the "Registration The Registration Statement included the audited financial statements of ANEW for the year ended December 31, 2022, which were audited by B.F. Borgers, CPA PC ("B. F. Borgers"). After learning that B. F. Borgers was no longer permitted to appear or practice before the SEC, ANEW engaged a new auditor, Yusufali & Associates, LLC, to re-audit ANEW's financial statements for the year ended December 31, 2022, audit ANEW's financial statements for the year ended December 31, 2023 and review the unaudited financial December 31, 2022 and December 31, 2023 and the unaudited financial statements for the quarterly period ended March 31, 2024 are attached hereto as exhibit 99.1 and 99.2, respectively, and are incorporated herein by reference. IMPORTANT NOTICES Important Notice Regarding Forward-Looking This Current Report on Form 8-K contains certain "forward-looking statements" within the meaning of the Securities Act and the Exchange Act both as amended. perspectives and expectations, are forward-looking state
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Audited Financial Statements of ANEW MEDICAL, INC. for the fiscal years ended December 31, 2022 and December 31, 2023 99.2 Unaudited Financial Statements of ANEW MEDICAL, INC. for the quarterly period ended March 31, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 20, 2024 REDWOODS ACQUISITION CORP. By: /s/ Jiande Chen Name: Jiande Chen Title: Chief Executive Officer 3